Combined inactivation of the SOS response with TCA fumarases and the adaptive response enhances antibiotic susceptibility against Escherichia coli
Overall, no significant differences or only moderate increases in susceptibility were observed in the single mutants, with Δ<i>fumC</i> and Δ<i>aidB</i> mutants showing the highest susceptibility. To enhance this effect, these genes were then inactivated in combination with the SOS response by constructing Δ<i>fumC</i>/Δ<i>recA</i> and Δ<i>aidB</i>/Δ<i>recA</i> mutants. These combinations exhibited significant differences in susceptibility to various antimicrobials, particularly cephalosporins and quinolones, and especially in the Δ<i>fumC</i>/Δ<i>recA</i> strain. To further assess these results, we constructed an <i>E. coli</i> ST131 Δ<i>fumC</i>/Δ<i>recA</i> mutant, in which a similar trend was observed. Together, these findings suggest that co-targeting the SOS response together with fumarases or the adaptive response could enhance the effectiveness of antibiotics against <i>E. coli</i>, potentially leading to new therapeutic strategies.
Authors
- María Romero-Muñoz
- Marina Murillo-Torres
- Sara Díaz-Díaz (ORCID: https://orcid.org/0000-0002-4864-1558)
- Esther Recacha (ORCID: https://orcid.org/0000-0001-7555-2924)
- Fernando Docobo-Pérez (ORCID: https://orcid.org/0000-0003-4038-6764)
- José Manuel Rodríguez-Martínez (ORCID: https://orcid.org/0000-0002-2228-2294)
- Isabel María Peñalver-Fernández
- Marta Quero-Delgado
Institutions
- Instituto de Salud Carlos III (ES)
- Hospital Universitario Virgen Macarena (ES)
- Centro de Investigación Biomédica en Red (ES)
- Instituto de Biomedicina de Sevilla (ES)
- Universidad de Sevilla (ES)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2025-05-09
- DOI
- https://doi.org/10.3389/fmicb.2025.1570764
- Primary Topic
- Bacterial Genetics and Biotechnology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universidad de Sevilla
- Consejería de Transformación Económica, Industria, Conocimiento y Universidades
- European Commission
- Instituto de Salud Carlos III
- European Social Fund